Citi Adds Kymera Therapeutics (KYMR) to 90-Day Upside Catalyst Watch
Tweet Send to a Friend
Citi analyst Geoff Meacham reiterated a Buy rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
